Compression stockings for preventing deep vein thrombosis in airline passengers

Clarke, Mike; Broderick, Cathryn; Hopewell, Sally; Juszczak, Ed; Eisinga, Anne

doi:10.1002/14651858.cd004002.pub3

Cited by 54 publications

(19 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…31 We propose the use of either compression stockings or prophylactic intensity anticoagulation in all patients with prior PE who have discontinued anticoagulant therapy and plan long-haul air flights (>4 h). 32 , 33 Twelve of the 16 panel members would prescribe a NOAC when it is decided to treat with pharmacological thromboprophylaxis, while four preferred low molecular weight heparin. Fifteen of 16 panel members would start pharmacological thromboprophylaxis on the day of the flight rather than the day before, and 10 would extend the duration of pharmacological thromboprophylaxis to 2–4 days following the flight in light of the increased risk of VTE that may persist for several days.…”

Section: Sports Lifestyle and Travelmentioning

confidence: 99%

Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society

Klok

Ageno

et al. 2021

European Heart Journal

102

View full text Add to dashboard Cite

This position paper provides a comprehensive guide for optimal follow-up of patients with acute pulmonary embolism (PE), covering multiple relevant aspects of patient counselling. It serves as a practical guide to treating patients with acute PE complementary to the formal 2019 European Society of Cardiology guidelines developed with the European Respiratory Society. We propose a holistic approach considering the whole spectrum of serious adverse events that patients with acute PE may encounter on the short and long run. We underline the relevance of assessment of modifiable risk factors for bleeding, of acquired thrombophilia and limited cancer screening (unprovoked PE) as well as a dedicated surveillance for the potential development of chronic thromboembolic pulmonary hypertension as part of routine practice; routine testing for genetic thrombophilia should be avoided. We advocate the use of outcome measures for functional outcome and quality of life to quantify the impact of the PE diagnosis and identify patients with the post-PE syndrome early. Counselling patients on maintaining a healthy lifestyle mitigates the risk of the post-PE syndrome and improves cardiovascular prognosis. Therefore, we consider it important to discuss when and how to resume sporting activities soon after diagnosing PE. Additional patient-relevant topics that require Focused counselling are travel and birth control.

show abstract

Section: Sports Lifestyle and Travelmentioning

confidence: 99%

Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society

Klok

Ageno

et al. 2021

European Heart Journal

102

View full text Add to dashboard Cite

show abstract

“…Long time ago travel fatigue has been known by sports community as inspiring problems that could benefit from practical resolutions ( Hanson, 1975 ; Samuels, 2012 ). Amongst them, peripheral oedema has been described ( Clarke et al, 2016 ), as the continued sitting in plane seats is related with a fluid accumulation in the legs during the first hours ( Mittermayr et al, 2007 ). Therefore, low-ankle-pressure graduated-compression tights may reduce flight-induced ankle oedema and subjectively-rated symptoms ( Hagan and Lambert, 2008 ).…”

Section: Management Strategies To Reduce Travel Fatiguementioning

confidence: 99%

Brief ideas about evidence-based recovery in team sports

Calleja-González¹,

Mielgo-Ayuso²,

Sampaio³

et al. 2018

J Exerc Rehabil

View full text Add to dashboard Cite

Performance in team sports is the expression of complex, dynamic, interactive, and multidimensional processes. It is now well-established that optimum recovery after practice or match is a key factor of team sport performance. During season and tournaments, improving recovery could offer an advantage for following performance. As a consequence of the professionalization of different roles in staffs, new particular roles have been developed within the team sports physician core in order to improve recovery protocols. Presently, scientific literature presents a big amount of methods used to enhance recovery based on the type of practice, time between session or competitions and equipment and/or staff accessible. These practices, usually used by teams are related to: ergonutritional, water therapy, massages techniques, stretching compression garments, sleep strategies and psychological implements. Besides, travel fatigue has been recognized by athletes and coaches as a challenging problem that could benefit from practical solutions. Nowadays, players have to play a lot of matches without enough time to recover among them, therefore the use of well-managed recovery can lead to a competitive advantage. Although the main purpose of applied sport sciences investigation is to categorize the protocols as well as providing approaches for individual recovery, the stages to recognize the most appropriate recovery plans in the field of team sports come from the analysis of the individual parameters.

show abstract

“…Air travel presents a special case of immobility and the occurrence of deep vein thrombosis has been well documented in this setting and the efficacy of interventions investigated (Clarke et al, 2016). (Sohail and Fischer, 2005) reiterate the finding of deep vein thrombosis in their review of air travel and health-related conditions but also cite cases of arterial thrombi although less frequent.…”

Section: Resultsmentioning

confidence: 99%

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review

Marley

2020

Preprint

View full text Add to dashboard Cite

BackgroundThe COVID-19 pandemic has claimed over 1 million lives globally and results from the SARS-COV2 virus. COVID-19 is associated with a coagulopathy. In this mixed-methods PRISMA-compliant scoping review, we set out to determine if ARDS, sepsis and DIC could account for the coagulopathy and if there were any other features of the coagulopathy we could determine so as to inform future research. Methods: We used a search strategy to identify papers with clinically relevant thromboembolic events in COVID-19. We then developed a technique referred to as an Abridged Thematic Analysis (ATA) to quickly identify themes in the papers so as to increase the yield of clinically relevant information. We further developed Validated Abridged Thematic Analysis (VATA) to validate the resulting taxonomy of themes. Finally we developed a number of methods that can be used by other researchers to take forwards this work. Results: We identified 56 studies with 10,523 patients, 456 patients with COVID-19 and thromboembolic events (TBE’s) and 586 thrombembolic events. There were an average of 1.3 TBE’s per patient. There were five main arterial territories with corresponding clinical sequelae: Acute limb ischaemia, myocardial infarcts, strokes, mesenteric ischaemia and pulmonary embolism. We also identified DVT’s. There were two further groups: medical-device-related coagulopathy and dermal lesions. In a subgroup of 119 patients we found mortality ranged from 26% in DVT to 79% in acute limb ischaemia although there was evidence of selection bias in the latter group. All patients were hospitalised and the average age of survivors was 63 versus 73 for those who died. 91/150 patients with TE’s had fever. From the ATA, we identified 16 characteristics of the clotting pathology in COVID-19. From the VATA, we identified 34 mechanisms leading to coagulopathy and grouped them according to Virchow’s triad of vascular damage, stasis and hypercoagulability. Coagulopathy occurred with and without each of ARDS, Sepsis and DIC. We conclude that COVID-19 leads to the syndrome of a viral clotting fever in a subgroup of patients and that the presentation of coagulopathy and fever should raise the possibility of COVID-19 as a differential. We make recommendations for future research studies.

show abstract

Compression stockings for preventing deep vein thrombosis in airline passengers

Cited by 54 publications

References 32 publications

Brief ideas about evidence-based recovery in team sports

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review

Contact Info

Product

Resources

About